The most recently added documents are listed below. To narrow down the results into the key area you are interested in, select the relevant term and press search. You can narrow the results further by selecting more terms. Untick a selected box to remove that filter or click reset to start over.
Despite major national reforms aimed at bolstering Australia's water security over the last decade, the WASH situation in remote Indigenous communities has attracted little attention. This study sheds new light on this issue by assessing the status of WASH indicators (access, behaviours, health outcomes) and identifying obstacles that constrain progress.
World Health Organization strategic and technical advisory group for neglected tropical diseases: Working group on monitoring and evaluation meeting report
The aim of this analysis was to estimate the unit cost and to identify the key cost drivers of trachoma prevalence surveys conducted as part of GTMP.
This systematic review and meta-analysis analyzes published and unpublished population-based data for the causes of vision impairment and blindness from 1980 to 2014.
This study aimed to estimate the prevalence of active trachoma and associated risk factors among preschool-aged children in Dembia District, northwest Ethiopia.
The objective of this study was to determine the prevalence of and associated risk factors for active trachoma among children in selected woredas of North and South Wollo Zones in Amhara Region, Ethiopia.
This template has been developed to gather case studies specifically detailing collaboration, coordination and integration between WASH and NTDs programmes to promote improved practices.
This study analyzes whether the World Health Organization recommendation for surveillance surveys to be done 2 years after cessation of mass drug administration in districts formerly endemic for trachoma is sufficient to detect reemergence of disease
This study reports the sensitivity of MBA and ELISA using a set of specimens from individuals with ocular swab specimens positive by nucleic acid amplification tests (NAATs) and specificity of the MBA, ELISA, and LFA against a panel of pediatric specimens from nonendemic countries and evaluate the characteristics of the ELISA assay using different cutoffs and plate preparation approaches.
The WHO recommends 3–5 years of annual mass azithromycin distribution with at least 80% treatment coverage to districts with active trachoma prevalence over 10% among children. This article assesses the efficacy of expanding the coverage target to at least 90% for trachoma control in a mesoendemic region of Niger.